Canadian HIV Vaccine Initiative – Large-Team Grants

Reporting Organization:Canadian Institutes of Health Research (CIHR)
Total Budget ($CAD):$ 12,000,000
Timeframe: March 9, 2010 - March 31, 2017
Status: Completion
Contact Information: Unspecified

Partner & Funder Profiles

Reporting Organization

Canadian Institutes of Health Research (CIHR)

Participating Organizations


Funders (Total Budget Contribution)

Return to top


Region - Total Budget Allocation

Sub-Saharan Africa - $ 10,576,800.00 (88.14%)

North Africa - $ 1,423,200.00 (11.86%)

Return to top

Areas of Focus

Health - Total Budget Allocation

HIV (100 %)

Return to top


The goal of the Large-Team Grants program under the Discovery and Social Research component of the Canadian HIV Vaccine Initiative (CHVI) is to make a significant contribution to HIV vaccine discovery and social research, and to train the next generation of HIV vaccine researchers. Funded teams are expected to strengthen links between researchers in Canada and those in low- and middle-income countries (LMIC) to increase integration and facilitate the sharing of research data and knowledge. The program, as part of the component, makes a significant contribution to research and research capacity focussed on: the discovery of HIV vaccines and related issues, and social and behavioural issues around HIV vaccines. Teams co-led by Canadian and LMIC researchers receive support for projects that build on their relevant skills and expertise and align with the Global Enterprise’s Scientific Strategic Plan.

Return to top

Target Population

Gender and age: Unspecified
Total Direct Population: Unspecified
Return to top



Return to top

Results & Indicators

Expected Results


Achieved Results

Results achieved as of March 2013 include: nine collaborative teams of Canadian and low- and middle-income country researchers received funding to support the development of Large Team Grant – HIV/AIDS Vaccine Discovery and Social Research program applications; five teams were awarded multi-year funding and are conducting HIV/AIDS vaccine discovery and social research; a stronger partnership between Canadian and African research partners was developed; new collaborations have been established between the research teams; synergies and complementarities within the program, with other Canadian HIV Vaccine Initiative components, and other global efforts were strengthened.


  • None Selected
Return to top
Return to top

Associated Projects (If applicable)

Return to top